Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells
Open Access
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 30 (3) , 1227-1238
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Generation of CD4CreERT2 transgenic mice to study development of peripheral CD4‐T‐cellsGenesis, 2012
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Nature Immunology, 2012
- A prospective analysis of lymphocyte phenotype and function over the course of acute sepsisCritical Care, 2012
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011
- Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling PathwaysMolecular and Cellular Biology, 2011
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- CD4 T cells: fates, functions, and faultsBlood, 2008
- Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral InfectionImmunity, 2007
- The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunityNature Immunology, 2005
- Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune diseaseNature, 2002